StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also issued reports on the company. Jefferies Financial Group lowered Reata Pharmaceuticals from a buy rating to […]
StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock. Several other research analysts have also commented on RETA. LADENBURG THALM/SH SH lowered shares of Reata Pharmaceuticals from a buy rating to a neutral rating and […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) SVP Andrea Loewen sold 3,175 shares of Reata Pharmaceuticals stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $172.03, for a total value of $546,195.25. Following the sale, the senior vice president now directly owns 28,416 shares in the […]